Clinical Trial Update: A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate D-2570 for moderate to severe plaque psoriasis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• D-2570

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING